Would this be compelling enough data, especially with our safety profile, to issue a conditional approval while we ran a confirmatory trial?
Also, are there any results that you think we could achieve in the mssCRC trial that might warrant a conditional approval?
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-